Moderate riskFDA DrugClass II

Baxter Pantoprazole Sodium injection recalled for manufacturing quality deviations

Baxter Healthcare Corporation is recalling one lot of Pantoprazole Sodium in 0.9% Sodium Chloride Injection due to deviations from current good manufacturing practices (CGMP). The affected lot was distributed in the United States, Puerto Rico, and Chile.

From the FDA notice · Read the official notice ↗ · All Baxter recalls

What to do

  1. Check your facility inventory for lot NC194129 with expiration date 05/07/2028.
  2. Do not use this lot; quarantine and return it to your supplier or Baxter Healthcare Corporation.
  3. Contact your pharmacy, hospital, or medical supplier for instructions on replacement product.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12.
Sold in
Nationwide
Made for
Adults

This recall covers 17 products — see all of them.

Details

Units affected
N/A
Illnesses reported
None reported
Manufactured in
1 Baxter Pkwy, N/A, Deerfield, IL, United States
Classification
Class II
Recall number
D-0812-2026

In the FDA's words

Description
Pantoprazole Sodium in 0.9% Sodium Chloride Injection, 80 mg/100 mL (0.8 mg/mL) Single-Dose Infusion Bag in 100 mL GALAXY Container, Rx only, Sterile, Baxter Healthcare Corporation, Deerfield, IL, 60015, USA, NDC 0338-9648-12. CGMP Deviations Lot # NC194129, Exp Date: 05/07/2028. Distribution: US Nationwide; Puerto Rico; and Chile. Affected quantity: N/A
Hazard
CGMP Deviations

17 products in this recall

Baxter IV drug bags recalled for manufacturing quality issues

Baxter is recalling 17 intravenous (IV) drug products for manufacturing quality problems, called CGMP deviations, which are lapses in the required production standards. The products include vancomycin, daptomycin, clindamycin, famotidine, dexmedetomidine, vasopressin, pantoprazole, insulin, nicardipine, and amiodarone, plus the brand names Myxredlin, CARDENE IV, and Nexterone. They were distributed nationwide, in Puerto Rico, and in Chile, and no injuries have been reported.

The agency lists each product separately. Check every one you might have.

More from Baxter

See all

Related topics

OtherDrugsSold nationwideMore from FDA Drug